Excella GmbH & Co. KG
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Germany
- Registered address
- Nuernberger Str. 12, Feucht, Bavaria 90537, Germany (DEU)
- Operations here
- analysisapi manufacturelabelmanufacturepack
- FDA identifiers
- FEI 3000242652 · DUNS 329809800
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2022-10-19
- VAIDrug Quality Assurance2019-07-12
- NAIDrug Quality Assurance2017-03-17
- VAIDrug Quality Assurance2015-05-29
- VAIDrug Quality Assurance2013-05-17
- VAIDrug Quality Assurance2012-10-10
- NAIDrug Quality Assurance2010-03-12
Drugs this plant is listed as making
6 distinct drugs across 27 products name this site in their FDA label.
- capecitabineH2-Pharma, LLC
- deferoxamine mesylateMitem Pharma
- Levothyroxine SodiumAccord Healthcare Inc.
- macitentanActelion Pharmaceuticals US, Inc.
- paroxetineLegacy Pharma USA, Inc.
- SelexipagActelion Pharmaceuticals US, Inc.
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.